Behavioral and neurobiological effects of GnRH agonist treatment in mice—potential implications for puberty suppression in transgender individuals
Autor: | Anke A. Ehrhardt, Briana K. Chen, Ryan Shores, Christine A. Denny, Heino F. L. Meyer-Bahlburg, Ezra Sydnor, Walter O. Bockting, William Byne, Bruce S. McEwen, Alessia Mastrodonato, Rushell S Dixon, Josephine C. McGowan, Christina C LaGamma, Christoph Anacker, Holly C. Hunsberger |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Agonist Gender dysphoria medicine.medical_specialty Adolescent medicine.drug_class Secondary sex characteristic medicine.medical_treatment Transgender Persons Dysphoria Article Gonadotropin-Releasing Hormone Mice 03 medical and health sciences 0302 clinical medicine Internal medicine Transgender medicine Animals Humans Pharmacology business.industry Dentate gyrus Puberty Gender Identity medicine.disease United States 030227 psychiatry Mice Inbred C57BL Psychiatry and Mental health Endocrinology Female Hormone therapy medicine.symptom business 030217 neurology & neurosurgery Hormone |
Zdroj: | Neuropsychopharmacology |
ISSN: | 1740-634X 0893-133X |
DOI: | 10.1038/s41386-020-00826-1 |
Popis: | In the United States, ~1.4 million individuals identify as transgender. Many transgender adolescents experience gender dysphoria related to incongruence between their gender identity and sex assigned at birth. This dysphoria may worsen as puberty progresses. Puberty suppression by gonadotropin-releasing hormone agonists (GnRHa), such as leuprolide, can help alleviate gender dysphoria and provide additional time before irreversible changes in secondary sex characteristics may be initiated through feminizing or masculinizing hormone therapy congruent with the adolescent’s gender experience. However, the effects of GnRH agonists on brain function and mental health are not well understood. Here, we investigated the effects of leuprolide on reproductive function, social and affective behavior, cognition, and brain activity in a rodent model. Six-week-old male and female C57BL/6J mice were injected daily with saline or leuprolide (20 μg) for 6 weeks and tested in several behavioral assays. We found that leuprolide increases hyperlocomotion, changes social preference, and increases neuroendocrine stress responses in male mice, while the same treatment increases hyponeophagia and despair-like behavior in females. Neuronal hyperactivity was found in the dentate gyrus (DG) of leuprolide-treated females, but not males, consistent with the elevation in hyponeophagia and despair-like behavior in females. These data show for the first time that GnRH agonist treatment after puberty onset exerts sex-specific effects on social- and affective behavior, stress regulation, and neural activity. Investigating the behavioral and neurobiological effects of GnRH agonists in mice will be important to better guide the investigation of potential consequences of this treatment for youth experiencing gender dysphoria. |
Databáze: | OpenAIRE |
Externí odkaz: |